DSIP user experiences: what users themselves report
Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.
This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: DSIP dosage in studies.
In short
Of 65 people, 38 (58%) said DSIP brought some benefit and 27 (42%) some harm.
- An AI model read and classified 213 public Reddit posts one by one, following written instructions. 75 were first-hand accounts, from 65 different people.
- Benefits mentioned most often: better sleep (18, 28%), deeper or more restful sleep (17, 26%) and daytime alertness (11, 17%).
- Harms mentioned most often: insomnia or worse sleep (18, 28%), grogginess or fatigue (5, 8%) and disturbing dreams or nightmares (4, 6%). In addition, 9 (14%) described some other, rarer harm. People tend to post when something goes wrong, so this share does not tell how common harms are.
- The effect on sleep split in two: 18 (28%) reported better sleep and 18 (28%) insomnia or worse sleep. 31 people (48%) used other substances at the same time.
- The accounts cannot separate the substance from placebo or other causes. What the research shows: DSIP: what the research shows.
Where the accounts come from and how we read them
Sources: the Reddit forums r/Peptides (42 accounts), r/Biohackers (30), r/Nootropics (2) and r/DSIP (1), 19 Oct 2024 to 9 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about DSIP, 213 were picked at random, and every one was read.
Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.
Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (21 posts) again without seeing the first classification. The main fields matched: 21/21 (100%).
Whose accounts these are: routes mentioned: injection 12, nasal spray 7; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.
Did DSIP help? The overall picture
Of 65 people, 25 (38%) reported benefit only, 13 (20%) both benefit and harm, 14 (22%) harm only and 13 (20%) neither.
Stopping. 9 people (14%) said they stopped or paused: 5 because of harms and 4 because they noticed no effect or for another reason.
| Overall picture: benefit, harm or neither | People | Share |
|---|---|---|
| Benefit only | 25 | 38% |
| Both benefit and harm | 13 | 20% |
| Harm only | 14 | 22% |
| Neither benefit nor harm | 13 | 20% |
Most common reported benefits
Of 65 people. 38 (58%) mentioned some benefit; the table lists every benefit reported.
| Reported | People | Share |
|---|---|---|
| Better sleep | 18 | 28% |
| Deeper or more restful sleep | 17 | 26% |
| Daytime alertness | 11 | 17% |
| Calmer, less stress | 3 | 5% |
| Recovery | 1 | 2% |
| Other benefit | 10 | 15% |
Share = people / 65.
Most common reported harms
Of 65 people. 27 (42%) mentioned some harm; 3 said explicitly they had none.
| Reported | People | Share |
|---|---|---|
| Insomnia or worse sleep | 18 | 28% |
| Grogginess or fatigue | 5 | 8% |
| Disturbing dreams or nightmares | 4 | 6% |
| Headache | 3 | 5% |
| Injection-site reaction | 3 | 5% |
| Anxiety or restlessness | 2 | 3% |
| Low mood | 2 | 3% |
| Other, rarer harm | 9 | 14% |
Share = people / 65.
How severe were the harms?
Of the 27 people who described how strong a harm was, 15 (56%) described it as mild, 11 (41%) as clearly bothersome and 1 (4%) as severe. The strength is the writer's own description, not a doctor's assessment.
| Strength of the harm as the writer described it | People | Share |
|---|---|---|
| Mild: minor and manageable | 15 | 56% |
| Clearly bothersome: several days, sleep or work affected | 11 | 41% |
| Severe: emergency visit, hospital or unable to function | 1 | 4% |
Harms known from research and regulators: What are the side effects of DSIP?
How long did people use DSIP?
30 of 65 people (46%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.
| Stated length of use | People | Share |
|---|---|---|
| Under a week | 21 | 70% |
| 1-4 weeks | 9 | 30% |
| 1-3 months | 0 | 0% |
| Over 3 months | 0 | 0% |
Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.
Other substances at the same time
31 of 65 people (48%) used other substances at the same time. The most common: retatrutide (11), Selank (11) and epitalon (10). Then the account cannot tell which substance had the effect.
About dosing
We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: DSIP dosage in studies. Legal status: Is DSIP legal in Finland?
What can be concluded?
As many people reported better sleep as worse sleep, so the accounts give no clear picture of how DSIP affects sleep. Periods of use were short.
The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: DSIP: what the research shows.
Quotes
Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.
-
"I have noticed better sleep quality and waking up feel much more refreshed after the nights I take it."
r/Peptides, 2025-11, Route and duration not stated. The writer reports better sleep quality and more refreshed waking, the most common benefit reported in the sample.
-
"it definitely helps with sleep quality and next day energy. This is more of a band-aid however"
r/Peptides, 2026-05, Route not stated, still in use. The writer has Lyme disease and feels it improves sleep and energy but does not fix the underlying cause.
-
"I found I had the most incredible deep sleep I've ever had. Problem is now I'm at work and still feeling, not groggy but floaty it's weird"
r/Peptides, 2025-09, Route not stated, first use. Sleep was very deep, but the next day the writer felt floaty and found detailed work hard.
-
"Sleep metrics show no difference from baseline and I did not experience anything different."
r/Peptides, 2026-05, Injected under the skin several times with varied timing. The writer noticed no effect and gave up, disappointed.
-
"If anything, my sleep seems worse. I wake up more frequently and my sleep feels lighter and less restorative."
r/Peptides, 2026-06, Nasal spray for about a week together with Epitalon. Brief drowsiness at first, but sleep became lighter and more broken. Worse sleep was the most common harm in the sample.
-
"The hangover didn't end up being worth it, so I decided to give it up, and get rid of it."
r/Biohackers, 2026-07, Route not stated, three nights of use. The writer stopped because of next-day grogginess and says sleep quality got worse after stopping.
Other summaries made with the same method: BPC-157 user experiences, Semax user experiences, Selank user experiences, Semax + Selank blend user experiences, Noopept user experiences and user experiences with collagen and skin peptides.
Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.